United States Vaccines Market 2025: Industry Developments, Future Growth, Share & Industry Insights | GSK plc, Merck & Co Inc, Pfizer Inc, CSL, EMERGENT

Global Vaccines Market reached US$ 77.01 billion in 2024 and is expected to reach US$ 108.82 billion by 2032, growing at a CAGR of 3.9% during the forecast period 2025-2032.

DataM Intelligence has published a new research report on "Vaccines Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/vaccines-market?sg

Regulatory:

✅ 22 May 2025 - FDA advised the U.S. COVID-19 vaccine composition for fall 2025 should be monovalent JN.1-lineage-based (guidance to manufacturers for the 2025-2026 season).

Mergers & acquisitions:

✅ 12 Jun 2025 - BioNTech announced a public exchange offer to acquire CureVac (strategic mRNA/oncology expansion).

✅ 22 Jul 2025 - Sanofi agreed to acquire Vicebio to add an RSV/hMPV combination candidate and Vicebio's "Molecular Clamp" vaccine tech.

Product launches / approvals / procurement:

✅ 31 Oct 2025 - Bavarian Nordic signed an EU procurement/framework contract for smallpox/mpox (MVA-BN) vaccines - framework covers up to ~8 million doses over the coming years (EU preparedness).

✅ 4 Sept 2025 - Novavax's Nuvaxovid® approved in Japan (Japan MHLW approval / triggers Takeda milestone arrangements and market entry).

✅ Aug-Sep 2025 - Pfizer/BioNTech rolled out their updated Comirnaty (LP.8.1 / JN.1-lineage sublineage) aligned with the FDA guidance for the 2025-2026 season.

Notable R&D / development updates (regional examples)

✅ 20 Feb 2025 - International Vaccine Institute (IVI) announced board / leadership moves and signalled expanded global vaccine projects (partnerships / capacity-building).

✅ 3 Nov 2025 - GC Biopharma published Phase-2 data for BARYTHRAX, a recombinant anthrax vaccine (safety & immunogenicity reported) - example of advancing biodefence/vaccine innovation from South Korea.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/vaccines-market?sg

Major Key Players:

Key players are GSK plc., Merck & Co., Inc., Pfizer Inc., CSL, EMERGENT, Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Bharat Biotech and Serum Institute of India Pvt. Ltd.

Market Growth Drivers:

✅ Rising Prevalence of Infectious Diseases:
Increased outbreaks of diseases such as influenza, measles, HPV, and COVID-19 continue to push demand for effective immunization solutions worldwide.

✅ Government Immunization Programs:
Large-scale vaccination initiatives led by WHO, UNICEF, and national health departments play a key role in expanding vaccine coverage, particularly in developing countries.

✅ Technological Advancements:
Innovations in mRNA technology, recombinant vaccines, and nanoparticle-based formulations have accelerated vaccine development and improved efficacy.

✅ Growing Geriatric and Pediatric Populations:
The increasing number of vulnerable populations requiring immunization-infants, elderly, and immunocompromised individuals-supports consistent vaccine demand.

✅ Public-Private Partnerships and Investments:
Collaborations between biotech firms, pharmaceutical companies, and government agencies have strengthened vaccine research pipelines and improved supply chain efficiency.

✅ Awareness and Preventive Healthcare Trends:
Rising awareness about the benefits of vaccination and preventive medicine is driving higher acceptance rates in both developed and developing economies.

Segments Covered in the Vaccines Market:

By Type - Conjugate Vaccines, Inactivated Vaccines, Live-attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Others

By Category - Monovalent Vaccines, Bivalent Vaccines, Multivalent Vaccines

By Disease Indication - Chickenpox, Cholera, Diphtheria, Influenza, Hepatitis, Measles, Mumps, Polio, Rabies, Others

By Route of Administration - Intramuscular, Subcutaneous, Intranasal, Others

By End User - Community Hospitals, Hospitals, Specialty Centers, Clinics, Others

By Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Regional Analysis for Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=vaccines-market?sg

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Vaccines Market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Vaccines Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Vaccines Market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Vaccines Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Vaccines Market?

➠ Who are the global key manufacturers of the Vaccines Market Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Vaccines Market opportunities and threats faced by the vendors in the global Vaccines Market Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Vaccines Market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.